Core Viewpoint - The company Ipsos has announced the launch of a new share buyback program aimed at enhancing shareholder returns, in addition to ongoing buybacks to mitigate dilution from employee share plans [2][3]. Group 1: Share Buyback Program Details - The share buyback program will involve a total expenditure of approximately €100 million, which is about 6.7% of the company's share capital based on the closing price of €34.46 on February 27, 2026 [3]. - The program is set to be completed by December 31, 2026, and is authorized by the resolutions from the Combined General Meeting held on May 21, 2025 [3]. - The company retains the right to suspend the buyback program at any time based on market conditions or its investment strategy [4]. Group 2: Company Overview - Ipsos is one of the largest market research firms globally, operating in 90 markets and employing nearly 20,000 people [5]. - The company offers 75 solutions based on primary data from surveys, social media monitoring, and qualitative techniques, aiming to provide insights into various stakeholders' actions and motivations [5]. - Founded in France in 1975, Ipsos has been publicly listed on Euronext Paris since July 1, 1999, and is part of the SBF 120 and Mid-60 indices [5].

TORONTO--(BUSINESS WIRE)--Greenland Resources Inc. (TSX:MOLY | FSE: M0LY) ("Greenland Resources†or the "Company†) is pleased to announce that the Government of Canada has conditionally approved the Company for a non-repayable contribution of up to $7,000,000 for the advancement of its Malmbjerg Molybdenum Optimization & Magnesium and Rare Earth By-product Feasibility Study project. Pending final diligence and definitive documentation, the funding will be provided through Natural Resources. ...

Company Overview - IDEXX is focused on supporting the veterinary profession and industry, which is viewed as an exceptional long-term opportunity with a total addressable market (TAM) exceeding $45 billion [3]. Strategic Focus - The company emphasizes the importance of diagnostic testing as foundational to veterinary practice and health, stating that it is essential for prescribing therapeutics, pharmaceuticals, or specialty diets [3][4]. - Diagnostic testing is also critical for assessing the basic health status of patients, highlighting its unique role in veterinary care [4].

As of 11:15 a.m. ET, Near Protocol (CRYPTO: NEAR) is among the biggest gainers in the cryptocurrency market, surging 13% over the past 24 hours. Let's dive into what's driving Near toward fresh monthly highs right now. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue » Why is Near surging today? Source: Getty Images. This move comes am ...

Key Takeaways Symbotic is expanding beyond warehouses with SymMicro, new storage and dock systems. SYM's Q1 FY26 RPO from multi-site deals supports revenue visibility over 15 years.Customer concentration and project timing remain as key risks for SYM. Symbotic (SYM) is benefiting from a durable, long-term push by retailers and wholesalers to automate warehouse operations. The demand backdrop is reinforced by multi-year contracts that provide revenue visibility and support a multi-year growth runway.That fou ...

Key Takeaways Escalating geopolitical risks are driving renewed safe-haven demand for gold.Gold prices are up 4.84% over the past five days and 52.41% over the past six months.ETFs like GLD and GDX can help investors ride gold's momentum.The Middle East, already marked by a fragile and complex geopolitical backdrop, saw tensions escalate on Saturday as the United States and Israel carried out strikes on Iran. This intensified global market volatility and drove investors toward safe-haven assets, strengtheni ...

Marimekko Corporation, Stock Exchange Release, 2 March 2026 at 6.45 p.m. EET Marimekko Corporation: Repurchase of own shares on 2 March 2026 Marimekko Corporation (LEI: 74370053IOY42B9YJ350) has acquired its own shares (ISIN FI0009007660) as follows: Trade date2 March 2026Bourse tradeBuyShareMEKKOVolume9,465Average price/share, EUR11.0685Total price, EUR104,763.35 On 12 February 2026, Marimekko announced that it will start acquiring the company’s own shares based on the authorization granted by the Annual G ...

Lyon (France), March 2, 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced its senior management will present and meet with investors at upcoming investor conferences in the United States and Europe. CEO Thomas Lingelbach and CFO Peter Buhler will discuss the Company’s key value drivers and upcoming catalysts, including the topline Phase 3 data readout for VLA15, the Company’s Lyme disease vaccine candidate, which partner Pfizer expects to report in the firs ...

Paramount Skydance has a good feeling about European approval for its $111B takeover of Warner Bros. Discovery (WBD). Andy Gordon, Par’s Chief Strategy Officer and Chief Operating Officer, told Wall Street analysts that his company had “already made significant progress in securing regulatory clearances globally” prior to the WBD dramatically deal closing last week. News had previously broken that the European Commission made the unusual move of beginning probes into both Paramount and Netflix’s offers for ...

Ivry-sur-Seine – France, March 2, 2026 Regulated information INFORMATION ON THE TOTAL NUMBER OF SHARES AND VOTING RIGHTS Statement in compliance with article L. 233-8 II of the French commercial code and article 223- 16 of the General Regulation of the French Financial Markets Authority (AMF – Autorité des marchés financiers) Stock MarketEuronext ParisISIN CodeFR0011476928Date Total number of shares composing the share capital of the companyTotal number of gross voting rights Total number of net voting rig ...